NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the non-invasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy in the United States, Israel, Europe, Australia, India, and internationally. The company's product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. It also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements. The company was incorporated in 2003 and is headquartered in Tyler, Texas.
| 0.7508 | |
| 0.729 | |
| - | |
| 0.7725 | |
| 0.729 | |
| 0.6685-4.23 | |
| 2 049 K | |
| 2 784 K | |
| 2 850 K | |
| -0.2342 | |
| 1.538 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
CARMEL, Ind., Jan. 31, 2022 /PRNewswire/ -- AM Best, the global credit rating agency for the insurance industry, recently upgraded the financial strength rating of CNO Financial Group (NYSE: CNO) and ...
Strengthens Board with Strategic, Corporate Governance and Financial Expertise ELMSFORD, N.Y., January 13, 2022--(BUSINESS WIRE)--NanoVibronix Inc., (NASDAQ: NAOV), a medical device company that prod...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
